Skip to content
10-K

Annual Report

IR-MED, INC

0001641172-25-002748

← back to feed
Filed
Apr 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 4, 2025 72.01M sh
Shares Diluted FY 2024 · Dec 31, 2024 70.47M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 −$1.39M
Cash And Equivalents FY 2024 · Dec 31, 2024 $129K
Stockholders Equity FY 2024 · Dec 31, 2024 −$294K
Current Liabilities FY 2024 · Dec 31, 2024 $545K
Total Liabilities FY 2024 · Dec 31, 2024 $545K
Current Assets FY 2024 · Dec 31, 2024 $205K
Total Assets FY 2024 · Dec 31, 2024 $251K
Eps Diluted FY 2024 · Dec 31, 2024 −$0.03
Eps Basic FY 2024 · Dec 31, 2024 −$0.03
Sga Expense FY 2024 · Dec 31, 2024 $1.01M
Rd Expense FY 2024 · Dec 31, 2024 $710K
Net Income FY 2024 · Dec 31, 2024 −$1.9M
Operating Income FY 2024 · Dec 31, 2024 −$1.94M